In the Guidance, the FDA posits that poor pharmaceutical label design can contribute to medication errors. To reduce such errors, the FDA seemingly takes a "pro-trade dress" stance by warning ...

According to Alok Nigam, Managing Director, Brother India, manufacturing technologies in the printing, communication, and digital imaging, noted that medication errors impact over 7 million patients ...

Pharmaceutical manufacturers are increasingly using primary containers made of plastics. In the case of soft plastics, there is a ...

Supernus Pharmaceuticals, Inc. announced that the FDA has approved an updated label for Qelbree (viloxazine extended-release capsules) to include new pharmacodynamic data, highlighting its ...

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...